Testing effectiveness (Phase 2)Study completedNCT03102047
What this trial is testing
Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer
Who this might be right for
Rectal Cancer
NSABP Foundation Inc 45